Data for ST001673   

(Analysis AN002731): Average values per metabolite and experimental factor (Units:pmols)

Metabolite structureAll dataF1F2F3F4F5
C14-Cer
9.74 19.24 9.11 15.23 11.81
C14HexosylCer
4.06 6.20 3.30 9.69 3.42
C14Lact-Cer
- - - 0.49 0.55
C14-SM
110.27 174.35 113.92 128.29 122.60
C16-Cer
27.73 54.64 27.37 73.29 36.26
C16HexosylCer
104.45 142.48 76.87 412.48 82.96
C16Lact-Cer
62.44 57.84 83.91 28.57 41.71
C16-SM
2086.45 2906.83 2152.66 2892.45 2174.12
C18_1-Cer
6.07 7.28 5.51 4.47 6.06
C18_1HexosylCer
1.54 1.63 1.50 1.56 1.48
C18_1Lact-Cer
0.88 1.06 1.09 0.69 0.76
C18_1-SM
60.81 63.20 59.95 50.44 58.21
C18-Cer
14.70 20.36 14.61 17.51 15.22
C18HexosylCer
9.90 11.12 7.89 34.52 7.63
C18Lact-Cer
8.93 10.52 13.60 4.48 6.88
C18-SM
210.14 257.63 210.75 239.33 190.98
C20_1-Cer
3.20 5.03 3.00 2.37 2.94
C20_1HexosylCer
2.64 3.94 2.25 3.39 2.02
C20_1Lact-Cer
1.15 1.53 1.68 0.78 1.07
C20_1-SM
28.13 41.12 27.96 20.58 25.25
C20-Cer
12.47 21.10 13.29 16.82 11.16
C20HexosylCer
7.23 8.07 5.60 17.22 5.38
C20Lact-Cer
2.48 2.59 3.88 1.47 2.12
C20-SM
63.61 88.66 59.60 59.65 55.31
C22_1-Cer
40.41 84.49 40.51 30.63 45.11
C22_1HexosylCer
23.17 40.88 17.60 29.45 14.73
C22_1Lact-Cer
7.04 10.03 12.53 3.57 6.03
C22_1-SM
358.99 550.01 343.68 203.94 347.53
C22-Cer
72.11 140.95 75.95 100.91 67.75
C22HexosylCer
218.40 303.73 172.26 443.34 179.26
C22Lact-Cer
34.69 47.09 57.14 13.29 33.77
C22-SM
269.19 368.88 252.93 207.94 270.49
C24_1-Cer
315.31 585.73 338.79 437.90 247.92
C24_1HexosylCer
669.63 923.90 558.89 1159.61 489.19
C24_1Lact-Cer
138.89 178.69 225.48 56.46 108.77
C24_1-SM
2483.34 3732.46 2390.75 2113.40 2482.48
C24-Cer
118.56 184.47 114.54 145.63 111.60
C24HexosylCer
340.39 469.90 267.23 648.24 303.12
C24Lact-Cer
48.36 48.11 69.42 20.69 43.08
C24-SM
196.51 276.19 171.06 167.60 233.53
C26_1-Cer
4.52 8.05 4.48 5.12 3.61
C26_1HexosylCer
22.17 33.80 18.52 32.04 22.20
C26_1Lact-Cer
4.87 5.98 6.61 3.34 4.88
C26_1-SM
13.57 26.70 12.63 12.46 17.34
C26-Cer
0.87 1.22 0.81 1.05 0.66
C26HexosylCer
4.02 4.51 3.51 4.69 3.84
C26Lact-Cer
2.29 2.53 2.45 2.08 2.25
C26-SM
2.29 2.82 2.28 2.35 2.54

Factors:

F1Treatment:GOLPH3 overexpression
F2Treatment:GOLPH3 silencing
F3Treatment:LCS overexpression
F4Treatment:LCS silencing
F5Treatment:no treatment
  logo